CAS 89180-45-0: 5-Chloro-2-hydroxypyrazine
Formula:C4H3ClN2O
InChI:InChI=1/C4H3ClN2O/c5-3-1-7-4(8)2-6-3/h1-2H,(H,7,8)
- Synonyms:
- 5-Chloropyrazin-2-Ol
- 5-chloropyrazin-2(1H)-one
- 2-Hydroxy-5-Chloropyrazine
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 5-Chloro-2(1H)-pyrazinone REF: IN-DA0036QFCAS: 89180-45-0 | 98% | To inquire | Tue 04 Mar 25 |
 | 5-Chloro-2-hydroxypyrazine REF: 54-OR301051CAS: 89180-45-0 | 98+% | 32.00 €~1,266.00 € | Tue 11 Mar 25 |
 | 5-Chloro-2-hydroxypyrazine REF: 10-F076747CAS: 89180-45-0 | 95.0% | To inquire | Wed 12 Mar 25 |
 | 5-Chloropyrazin-2-ol REF: 3D-FC139817CAS: 89180-45-0 | Min. 95% | - - - | Discontinued product |
5-Chloro-2(1H)-pyrazinone
CAS:89180-45-0
Formula:
C4H3ClN2O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
130.5324
Ref: IN-DA0036QF
| 1g | 49.00 € | ||
| 5g | 95.00 € | ||
| 10g | 150.00 € | ||
| 25g | 263.00 € | ||
| 2.5g | 59.00 € | ||
| 250mg | 26.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
5-Chloro-2-hydroxypyrazine
CAS:89180-45-0
Formula:
C4H3ClN2O
Purity:
98+%
Color and Shape:
yellow powder
Molecular weight:
130.53g/mol
Ref: 54-OR301051
| 1g | 32.00 € | ||
| 5g | 88.00 € | ||
| 25g | 357.00 € | ||
| 100g | 1,266.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
5-Chloro-2-hydroxypyrazine
CAS:89180-45-0
Purity:
95.0%
Color and Shape:
Solid
Molecular weight:
130.52999877929688
Ref: 10-F076747
| 1g | 25.00 € | ||
| 5g | 65.00 € | ||
| 10g | 110.00 € | ||
| 25g | 251.00 € | ||
| 100g | 932.00 € |
Estimated delivery in United States, on Wednesday 12 Mar 2025
5-Chloropyrazin-2-ol
CAS:89180-45-0
5-Chloropyrazin-2-ol is a synthetic chemical compound that contains a chlorine atom and pyrazines. It is …
Formula:
C4H3ClN2O
Purity:
Min. 95%
Molecular weight:
130.53 g/mol
Ref: 3D-FC139817
| 1g | Discontinued | Request information | |
| 2g | Discontinued | Request information | |
| 5g | Discontinued | Request information | |
| 10g | Discontinued | Request information | |
| 25g | Discontinued | Request information |
